About InPharmics
InPharmics is a company based in Madison (United States) founded in 2011 was acquired by Omnicell in April 2017.. InPharmics operates in a competitive market with competitors including Capsa Healthcare, Talyst, Pearson Medical Technologies, OpiSafe and Swisslog Healthcare, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of InPharmics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InPharmics
InPharmics has secured backing from 1 investor. Prominent investors backing the company include Omnicell. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Materials management and business analytics solutions for healthcare are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InPharmics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InPharmics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inpharmics Comparisons
Competitors of InPharmics
InPharmics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Capsa Healthcare, Talyst, Pearson Medical Technologies, OpiSafe and Swisslog Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medication management systems are supplied to healthcare providers and pharmacies.
|
|
| domain | founded_year | HQ Location |
Pharmacy management solutions are provided to hospitals and pharmacies.
|
|
| domain | founded_year | HQ Location |
Provider of pharmacy automation solutions
|
|
| domain | founded_year | HQ Location |
Practice management software for addiction treatment is provided.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive medication supply chain solutions for hospitals.
|
|
| domain | founded_year | HQ Location |
Inventories and workflows in pharmacies are managed through automated software.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about InPharmics
When was InPharmics founded?
InPharmics was founded in 2011.
Where is InPharmics located?
InPharmics is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
What does InPharmics do?
InPharmics was founded in 2011 in Madison, United States, within the healthcare sector. Solutions for medication and supply management in pharmacies are delivered via a platform featuring dispensing automation, central pharmacy systems, IV robotics, analytics tools, and medication oversight technology. Operations emphasize automation and data-driven efficiencies to support pharmacy workflows across healthcare settings.
Who are the top competitors of InPharmics?
InPharmics's top competitors include Capsa Healthcare, Pearson Medical Technologies and Talyst.
Who are InPharmics's investors?
InPharmics has 1 investor. Key investors include Omnicell.